Items

cnbc.com

The Senate passed a $1.9 trillion coronavirus relief package on Saturday as Democrats rush to send out a fresh round of aid.

The Democratic-held House aims to pass the bill on Tuesday and send it to President Joe Biden for his signature before a March 14 deadline to renew unemployment aid programs. The Senate approved the plan in a 50-49 party line vote as Republicans questioned the need for another broad spending package.

Submitted by Admin on Sat, 03/06/2021 - 20:16
dallasnews.com

AUSTIN — Texans will no longer be required to wear a face mask in public, and all businesses will be able open at full capacity starting next week, Gov. Greg Abbott announced Tuesday.

The Republican made the sweeping move — on Texas Independence Day — even though public health officials say restrictions are still critical to control the pandemic, which has killed more than 42,500 Texans.

Submitted by Admin on Wed, 03/03/2021 - 19:40

NEW BRUNSWICK, N.J., February 27, 2021 Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.

Submitted by Admin on Sat, 02/27/2021 - 20:09
npr.org

The grim milestones are piling up as the United States experiences another surge in coronavirus cases. Nearly 300,000 new cases were reported on Saturday. The cumulative death toll crossed more than 350,000 the same day, according to the Johns Hopkins University COVID-19 dashboard.

Submitted by Admin on Sun, 01/03/2021 - 18:52
cnn.com

(CNN)The US Food and Drug Administration has authorized the first Covid-19 vaccine for emergency use in the United States. Millions of doses of the Pfizer and BioNTech coronavirus vaccine, which has been found to be 95% effective, will be soon shipped around the country so vaccinations can begin within days.

Submitted by mo2 on Sat, 12/12/2020 - 21:03
npr.org

One of the experimental drugs that President Trump received while he was battling the coronavirus has been approved for emergency use by the Food and Drug Administration. The drug, made by the biotech company Regeneron, is the second antibody treatment to win emergency use approval from the FDA.

The treatment combines two antibodies — casirivimab and imdevimab — and administers them together by IV. In a clinical trial of about 800 people, the combination was shown to significantly reduce virus levels within days of treatment.

Submitted by mo2 on Sun, 11/22/2020 - 20:59
reuters.com

(Reuters) - Moderna Inc’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.

Together with Pfizer Inc’s vaccine, which is also more than 90% effective, and pending more safety data and regulatory review, the United States could have two vaccines authorized for emergency use in December with as many as 60 million doses of vaccine available this year.

Submitted by mo2 on Mon, 11/16/2020 - 20:55